Fourth-quarter and full-year profits surged for ConMed (NSDQ:CNMD) thanks to the tax reforms passed last year, as the medical device maker posted Street-beating sales and earnings numbers. Utica, N.Y.-based Conmed yesterday reported profits of $46.7 million, or $1.65 per share, on sales of $222.6 million for the three months ended Dec. 31, 2017. That’s a […]
Cerner taps former head of Philips North America to take over corner officer | Personnel Moves January 11, 2018
Cerner Corp. (NSDQ:CERN) said yesterday that it named Brent Shafer to serve as chairman & CEO effective Feb. 1. Shafer previously served as CEO of Philips‘ (NYSE:PHG) North America business. Cerner’s co-founder Cliff Illig has been serving as interim CEO and chairman of the board since July last year. Illig said he plans to resume […]
Hologic to retain CEO MacMillan | Personnel Moves – November 3, 2017
Hologic (NSDQ:HOLX) said this week its current prez and CEO Stephen MacMillan will stay on with the company, resolving rumors that he may depart it to take up the corner office at Zimmer Biomet (NYSE:ZBH). In an SEC filing, the Marlborough, Mass.-based company’s board said it approved a special “performance-based retention equity grant” to MacMillan after he had begun […]
ConMed ticks up on Street-beating Q3 results
ConMed (NSDQ:CNMD) shares ticked up today after the medical device company yesterday reported third-quarter results that topped Wall Street’s forecast and announced the retirement of its financial chief. Utica, N.Y.-based ConMed posted profits of $7.2 million, or 26¢ per share, on sales of $190.1 million for the three months ended Sept. 30, for a -1.9% […]
ConMed shares steady on Q2 beat
Shares in ConMed (NSDQ:CNMD) have stayed steady today after the device maker met expectation on Wall Street with its 2nd quarter earnings results. The Utica, N.Y.-based company posted profits of $6.1 million, or 22¢ per share, on sales of $197.2 million for the 3 months ended June 30, for bottom-line growth of 112.9% while sales grew […]
MedShape deals ExoShape ACL portfolio to ConMed
MedShape said today it inked a deal to divest its ExoShape ACL fixation system properties to ConMed (NSDQ:CNMD) for an undisclosed amount. The deal, which closed on Monday, includes Atlanta-based MedShape’s ExoShape femoral and tibial soft tissue fasteners designed to fixate soft tissue grafts in anterior cruciate ligament reconstructive surgery. “The ExoShape system has represented a […]
Lombard Medical CEO Hubbert, CFO Kullback step down | Personnel Moves, April 28, 2017
Lombard Medical Technologies (NSDQ:EVAR) said this month that its CEO Simon Hubbert and CFO William Kullback are stepping down from their positions, with Kurt Lemvigh stepping into the CEO role. Hubbert served as CEO for 6 years after joining the company in 2010, and will be replaced by Lemvigh, who has held positions with multiple companies, including […]
Conmed’s SurgiQuest loses $12m to Lexion in false advertising case
Conmed (NSDQ:CNMD) said today that a jury today returned a $12.2 million verdict against it and its SurgiQuest subsidiary in a false advertising case with Lexion Medical. The jury in the US Federal District Court for the District of Delaware found SurgiQuest liable for $2.2 million in compensatory damages and an additional $10 million in punitive damages, […]
ConMed licenses KFx rotator cuff repair patents
KFx Medical has inked a new licensing agreement with ConMed (NSDQ:CNMD) related to its knotless double row rotator cuff repair patents. Through the agreement, ConMed and its subsidiaries will have the right to market products and techniques for knotless double row rotator cuff repair. The companies said that approximately 1/3rd of the rotator cuff repairs in the […]
ConMed slides on Q4 earnings miss
ConMed (NSDQ:CNMD) shares are off some 6% this week after the medical device company missed expectations with its 4th-quarter earnings. Utica, N.Y.-based ConMed posted a -14.6% profit decline to $6.7 million, or 24¢ per share, on sales growth of 6.8% to $204.1 million for the 3 months ended Dec. 31, compared with Q4 2015. Adjusted […]
Bovie Medical inks distro deal for PlazXact Ablator
Bovie Medical (NYSE:BVX) said today it inked a global sales channel partnership deal with ConMed (NSDQ:CNMD) for its PlazXact Ablator. As part of the deal, Utica, N.Y.-based ConMed’s PlazXact Ablator will be marketed as the UltrAblator Bipolar series, effective March 2017, according to Bovie Medical. “Partnering with a company of ConMed’s reputation builds on Bovie’s strategy to scale […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 6
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube